Randomized controlled study for an effect of postprandial monitoring with oral hypoglycemic agent in type 2 diabetic patients

Randomized controlled study for an effect of postprandial monitoring with oral hypoglycemic agent in type 2 diabetic patients - Effect of postprandial monitoring with oral hypoglycemic agent in type 2 diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002062

Enrollment

100

Registered

2009-06-10

Start date

2008-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Operation of SMBG The control group of SMBG(Measurement:post for a fixed period of time)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c 5.8-9.0 in non-insulin type 2 diabetic patients

Exclusion criteria

Exclusion criteria: Insulin patients

Design outcomes

Primary

Measure	Time frame
HbA1c, glucose and lipid metabolism, inflammation, daily care include diet therapy	—

Countries

Japan

Contacts

Public ContactMunehide Matsuhisa

Osaka University School of Medicine Department of Endocrinology and Metabolism

06-6879-3633

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026